Suominen Corporation Manager's Transaction: Charles Héaulmé

2025-09-08 08:01:39

(MENAFN- GlobeNewsWire - Nasdaq) Suominen Corporation September 8, 2025 at 3:00 p.m. (EEST)

Charles Héaulmé has reported to have made transactions with Suominen Corporation's shares. The transactions are presented below as a summary, and in detail as per the disclosure requirement.

Acquisitions on September 5, 2025:

Total amount 397 shares
Volume weighted average price EUR 1.8800

Suominen Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Charles Héaulmé
Position: Chief Executive Officer
Issuer: Suominen Oyj
LEI: 743700Z1BNFYR9PRDF52
Notification type: INITIAL NOTIFICATION
Reference number: 122035/4/4

____________________________________________
Transaction date: 2025-09-05
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009010862
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 397 Unit price: 1.88 EUR

Aggregated transactions (1):
Volume: 397 Volume weighted average price: 1.88 EUR

SUOMINEN CORPORATION

For more information, please contact:
Janne Silonsaari, CFO, tel. +358 (0)50 409 9264

Suominen manufactures nonwovens as roll goods for wipes and other applications. Our vision is to be the frontrunner for nonwovens innovation and sustainability. The end products made of Suominen's nonwovens are present in people's daily life worldwide. Suominen's net sales in 2024 were EUR 462.3 million, and we have over 700 professionals working in Europe and in the Americas. Suominen's shares are listed on Nasdaq Helsinki. Read more at

Distribution:
Nasdaq Helsinki
Main media

MENAFN08092025004107003653ID1110030815

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.